Table 2 |
||||
|
Frequency of deformities and lethality in egfp TAL-injected embryos |
||||
|
Targeting nuclease(s) |
Wild type |
Abnormal |
Dead |
Total (N) |
|
|
||||
|
12.5 pg egfp5TAL |
86 (93.5%) |
6 (6.5%) |
0 (0%) |
92 |
|
25 pg egfp5TAL |
14 (23.0%) |
44 (72%) |
3 (4.9) |
61 |
|
12.5 pg egfp3TAL |
89 (96.7%) |
2 (2.2%) |
1 (1.1%) |
92 |
|
25 pg egfp3TAL |
53 (61.6%) |
28 (32.6%) |
5 (58.0%) |
86 |
|
12.5 pg egfp5TAL+egfp3TAL |
202 (82.8%) |
29 (11.9%) |
13 (5.3%) |
244 |
|
25 pg egfp5TAL+egfp3TAL |
40 (33.1%) |
62 (51.2%) |
19 (15.7%) |
121 |
|
|
||||
|
Numbers were tabulated from at least two independent experiments. |
||||
|
Lim et al. Genome Biology 2013 14:R69 doi:10.1186/gb-2013-14-7-r69 |
||||